 post-chemotherapi tumor residu patient advanc nonseminomat testicular cancer necessari residu mass total patient advanc nonseminomat testicular cancer underw sequenti oper patient residu mass cisplatin-bas combin chemotherapi patient normal human chorion gonadotropin alpha-fetoprotein level persist radiograph mass chemotherapi oper retroperiton lymph node dissect patient thoracotomi hepat resect craniotomi histolog comparison specimen post-chemotherapi oper differ pattern patient patient favor patholog featur specimen second procedur residu malign tumor matur teratoma site patient complet necrosi fibrosi specimen data favor impact post-chemotherapi tumor residu patient advanc nonseminomat testicular cancer patient teratomat element testicular tumor complet necrosi fibrosi initi post-chemotherapi oper specimen probabl complet necrosi fibrosi tumor high